Jubilant Cadista Pharmaceuticals Inc., USA's facility receives EIR from USFDA

Jubilant Pharmova Limited's subsidiary Jubilant Cadista Pharmaceuticals Inc., USA, (Jubilant Cadista)'s solid oral formulations facility at Salisbury, Maryland, USA (Facility) has received the Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the US Food and Drug Administration (USFDA) for the said Facility with respect to the inspection conducted by the said regulatory agency in January 2025.

With the receipt of the EIR from the USFDA, the inspection stands successfully closed.

Going forward, the said Facility is not expected to manufacture any products as it has closed manufacturing operations.

Shares of Jubilant Pharmova Limited was last trading in BSE at Rs. 866.60 as compared to the previous close of Rs. 865.25. The total number of shares traded during the day was 56080 in over 1742 trades.

The stock hit an intraday high of Rs. 893.30 and intraday low of 860.00. The net turnover during the day was Rs. 49486342.00.

Source : Equity Bulls

Keywords

JubilantPharmova INE700A01033 JubilantCadistaPharmaceuticals Salisbury SolidOralFormulations Facility Maryland EIR USFDA VAIStatus